HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noboru Oriuchi Selected Research

Amino Acid Transport Systems (Amino Acid Transporter)

10/2016Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
3/2016Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.
2/2016Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography.
11/2015CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
10/2015Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
9/2015Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
9/2015Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
1/2015Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.
1/2015Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.
11/2014Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noboru Oriuchi Research Topics

Disease

77Neoplasms (Cancer)
10/2021 - 02/2002
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2014 - 10/2004
9Lung Neoplasms (Lung Cancer)
01/2021 - 09/2003
8Hypoxia (Hypoxemia)
02/2014 - 12/2006
7Carcinoma (Carcinomatosis)
02/2010 - 09/2003
6Esophageal Squamous Cell Carcinoma
10/2016 - 09/2002
4Stomach Neoplasms (Stomach Cancer)
01/2018 - 04/2006
4Squamous Cell Carcinoma of Head and Neck
11/2015 - 06/2005
4Hepatocellular Carcinoma (Hepatoma)
09/2015 - 12/2007
4Pheochromocytoma
01/2014 - 02/2008
4Colorectal Neoplasms (Colorectal Cancer)
08/2012 - 01/2011
4Neoplasm Metastasis (Metastasis)
02/2010 - 01/2005
3Sarcoidosis (Schaumann Disease)
01/2018 - 12/2004
3Esophageal Neoplasms (Esophageal Cancer)
10/2016 - 09/2002
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2014 - 01/2008
3Cholangiocarcinoma
10/2013 - 01/2008
3Lymphatic Metastasis
10/2013 - 06/2008
3Sarcoma (Soft Tissue Sarcoma)
03/2012 - 12/2008
3Adenocarcinoma
11/2011 - 10/2009
3Lymphoma (Lymphomas)
06/2009 - 08/2006
2Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2014 - 10/2013
2Paraganglioma (Paragangliomas)
01/2014 - 06/2008
2Malignant Mesothelioma
05/2012 - 12/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2011 - 02/2009
2Ascites
03/2011 - 07/2005
2Breast Neoplasms (Breast Cancer)
04/2010 - 08/2006
2Head and Neck Neoplasms (Head and Neck Cancer)
02/2010 - 12/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2009 - 07/2005
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
03/2008 - 07/2004
1Brain Neoplasms (Brain Tumor)
10/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Inflammation (Inflammations)
03/2016
1Thyroid Neoplasms (Thyroid Cancer)
01/2016
1Melanoma (Melanoma, Malignant)
10/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2015
1Pancreatic Ductal Carcinoma
01/2015
1Multiple Myeloma
11/2014
1Adenoid Cystic Carcinoma (Cylindroma)
10/2013
1Neurilemmoma (Schwannoma)
09/2012
1Thymus Neoplasms (Thymus Neoplasm)
09/2012
1Teratoma (Teratoid Tumor)
09/2012
1Cysts
09/2012
1Ganglioneuroma
09/2012
1Rheumatoid Arthritis
08/2012

Drug/Important Bio-Agent (IBA)

33Amino Acid Transport Systems (Amino Acid Transporter)IBA
10/2016 - 04/2007
20Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2016 - 07/2003
17Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2004
17Deoxyglucose (2 Deoxy D glucose)IBA
01/2021 - 01/2003
17Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 12/2008
10HexokinaseIBA
02/2014 - 06/2005
9Amino AcidsFDA Link
09/2015 - 04/2007
9Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
02/2014 - 07/2003
9ErbB Receptors (EGF Receptor)IBA
02/2014 - 07/2003
8Monoclonal AntibodiesIBA
01/2020 - 07/2003
7Biological ProductsIBA
12/2014 - 08/2010
6Tyrosine (L-Tyrosine)FDA Link
05/2013 - 10/2010
4Biomarkers (Surrogate Marker)IBA
12/2014 - 05/2011
4Heavy Chain Fusion Regulatory Protein 1IBA
09/2010 - 02/2009
3Indicators and Reagents (Reagents)IBA
11/2015 - 10/2013
3Therapeutic UsesIBA
03/2014 - 03/2011
3alpha-Methyltyrosine (Metirosine)FDA Link
04/2007 - 01/2003
3Choline (Choline Chloride)IBA
07/2004 - 03/2003
2Protein Isoforms (Isoforms)IBA
03/2016 - 08/2012
2Indium-111IBA
03/2014 - 07/2009
23-Iodobenzylguanidine (Iobenguane)IBA
01/2014 - 06/2008
2AcidsIBA
10/2013 - 08/2009
2Yttrium-90IBA
08/2012 - 07/2009
2TensinsIBA
12/2011 - 01/2011
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2011 - 01/2011
2TOR Serine-Threonine KinasesIBA
11/2011 - 01/2011
2FluorineIBA
08/2011 - 01/2003
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2011 - 07/2009
2Bevacizumab (Avastin)FDA Link
01/2011 - 01/2011
2rhenium sulfide (ReS2)IBA
04/2006 - 09/2003
1Methionine (L-Methionine)FDA Link
10/2021
1Immune Checkpoint InhibitorsIBA
09/2020
1CXC ChemokinesIBA
01/2020
1S-1 plus cisplatinIBA
01/2018
1GlucocorticoidsIBA
01/2018
1Capecitabine (Xeloda)FDA Link
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Small Interfering RNA (siRNA)IBA
03/2016
1Radioisotopes (Radionuclides)IBA
01/2016
1AlbuminsIBA
09/2015
1Fetal Proteins (Fetoprotein)IBA
09/2015
1Matrix Metalloproteinases (MMPs)IBA
01/2015
1Iodine-131IBA
01/2014
1GemcitabineFDA Link
10/2013
1Fluorouracil (Carac)FDA LinkGeneric
10/2013
1Cadherins (E-Cadherin)IBA
08/2012

Therapy/Procedure

23Therapeutics
09/2020 - 06/2004
8Drug Therapy (Chemotherapy)
09/2020 - 10/2004
6Radioimmunotherapy
01/2020 - 07/2005
5Radiotherapy
10/2021 - 04/2006
3Aftercare (After-Treatment)
02/2010 - 07/2005
3Esophagectomy
10/2008 - 09/2003
2Chemoradiotherapy
11/2010 - 07/2007
2Gamma Cameras (Gamma Camera)
09/2003 - 07/2003
1Intravenous Injections
08/2012
1Injections
08/2012